Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-02 Purchase |
2021-07-06 4:26 pm |
Aerovate Therapeutics Inc. | AVTE | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC 10% Owner |
535,714 | $14 | $7,499,996 | 3,103,879 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-02 Conversion |
2021-07-06 4:26 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC 10% Owner |
10,544,919 | $0 | 3,103,879 (Direct) |
View |
| 2021-06-29 Option Award |
2021-07-01 6:36 pm |
N/A 2031-06-28 |
Aerovate Therapeutics Inc. | AVTE | Resnick Joshua Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:35 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Development Officer |
152,234 | $0 | 152,234 (Direct) |
View |
| 2021-02-01 Option Award |
2021-07-01 6:34 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
9,246,403 | $1.893 | 13,073,286 (Indirect) |
View |
| 2021-06-29 Option Award |
2021-07-01 6:34 pm |
N/A 2031-06-28 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
25,000 | $0 | 13,073,286 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:33 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
158,497 | $0 | 158,497 (Direct) |
View |
| 2021-02-01 Option Award |
2021-07-01 6:32 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
6,981,033 | $1.893 | 9,876,456 (Indirect) |
View |
| 2021-06-29 Option Award |
2021-07-01 6:32 pm |
N/A 2031-06-28 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
25,000 | $0 | 9,876,456 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:32 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P Chief Executive Officer |
1,018,834 | $0 | 1,018,834 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:31 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter Chief Medical Officer |
186,234 | $0 | 186,234 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:29 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A See Remarks |
226,426 | $0 | 226,426 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:28 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
558,603 | $0 | 558,603 (Direct) |
View |
Ownership |
2021-06-29 8:46 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC 10% Owner |
0 | $0 | 2,568,165 (Direct) |
View |
Ownership |
2021-06-29 8:44 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
0 | $0 | 2,568,165 (Indirect) |
View |
Ownership |
2021-06-29 7:44 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 5,478,268 (Indirect) |
View |
Ownership |
2021-06-29 7:43 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES 10% Owner |
0 | $0 | 3,401,544 (Direct) |
View |
Ownership |
2021-06-29 7:42 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
0 | $0 | 3,401,544 (Indirect) |
View |
Ownership |
2021-06-29 7:42 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Development Officer |
0 | $0 | 166,139 (Direct) |
View |
Ownership |
2021-06-29 7:42 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P Chief Executive Officer |
0 | $0 | 747,634 (Direct) |
View |
Ownership |
2021-06-29 7:41 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
0 | $0 | 116,297 (Direct) |
View |
Ownership |
2021-06-29 7:40 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter Chief Medical Officer |
0 | $0 | 166,139 (Direct) |
View |
Ownership |
2021-06-29 7:39 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A See Remarks |
0 | $0 | 149,526 (Direct) |
View |
Ownership |
2021-06-29 7:39 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
0 | $0 | 498,421 (Direct) |
View |
Ownership |
2021-06-29 5:09 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP 10% Owner |
0 | $0 | 1,530,691 (Indirect) |
View |